InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Selhorn Ryan J. Director active across 1 company, notably Aytu Biopharma, INC. In total, 5 disclosures have been published. Activity tracked since 11 November 2024. The latest transaction was disclosed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Selhorn Ryan J has 4 filings in total. In the 4 sampled recent filings, all involving Aytu Biopharma, INC, the modal transaction nature is Attribution, and the period runs from 2024-11-13 to 2025-10-07, with buy and sell amounts of 0 EUR.